All News about Axsome Thera
![](https://cdn.benzinga.com/files/images/story/2022/10/14/image26.jpeg?width=1200&height=800&fit=crop)
![](https://investorplace.com/wp-content/uploads/2022/09/social-security-1600.jpg)
![](https://investorplace.com/wp-content/uploads/2022/02/medical-tools-tech-therapeutics.png)
![](https://www.investors.com/wp-content/uploads/2021/04/Stock-Axsome-01-shutt.jpg)
![](https://cdn.benzinga.com/files/images/story/2022/10/13/image50.jpg?width=1200&height=800&fit=crop)
![](https://g.foolcdn.com/editorial/images/704011/biotech-pharma-researchers-talk-lab.jpg)
![](https://cdn.benzinga.com/files/images/story/2022/10/13/image47.jpg?width=1200&height=800&fit=crop)
![](https://cdn.benzinga.com/files/images/story/2022/10/13/image26.jpeg?width=1200&height=800&fit=crop)
![](https://g.foolcdn.com/editorial/images/704366/investor-excited-computer.jpg)
![](https://cdn.benzinga.com/files/images/story/2022/10/03/aapharma_6.png?width=1200&height=800&fit=crop)
![](https://cdn.benzinga.com/files/images/story/2022/analyst_ratings_image_4705.png?width=1200&height=800&fit=crop)
![](https://cdn.benzinga.com/files/images/story/2022/09/07/aapharma_11.png?width=1200&height=800&fit=crop)
Mizuho Bolsters Price Target By 55% On This Migraine Stock
September 07, 2022
Via Benzinga
![](https://g.foolcdn.com/editorial/images/704154/elderly-person-sitting-on-a-bed.jpg)
![](https://g.foolcdn.com/editorial/images/704354/scientists-work-in-lab-smiling.jpg)
![](https://ml.globenewswire.com/media/fb41e4f1-1df6-4dbd-8fd7-a02f94b7ae4c/small/axsome-logo-png.png)
![](https://investorplace.com/wp-content/uploads/2021/11/shutterstock_1667119063.png)
![](https://g.foolcdn.com/editorial/images/703838/gettyimages-1341523397.jpg)
![](https://cdn.benzinga.com/files/images/story/2022/analyst_ratings_image_25828.jpeg?width=1200&height=800&fit=crop)
![](https://cdn.benzinga.com/files/images/story/2022/10/07/stock-exchange-g894ab76ae_1920.jpg?width=1200&height=800&fit=crop)
![](https://g.foolcdn.com/editorial/images/703360/pharmacist_xeeHST2.jpeg)
![](https://ml.globenewswire.com/media/fb41e4f1-1df6-4dbd-8fd7-a02f94b7ae4c/small/axsome-logo-png.png)
Via GlobeNewswire
![](https://cdn.benzinga.com/files/images/story/2022/options_image_2129.jpeg?width=1200&height=800&fit=crop)
![](https://ml.globenewswire.com/media/fb41e4f1-1df6-4dbd-8fd7-a02f94b7ae4c/small/axsome-logo-png.png)
![](https://cdn.pixabay.com/photo/2015/12/15/09/00/success-1093891__480.jpg)
![](https://investorplace.com/wp-content/uploads/2021/12/shutterstock_1726134715.png)
![](https://investorplace.com/wp-content/uploads/2021/12/shutterstock_1726134715.png)
![](https://cdn.benzinga.com/files/images/story/2022/09/08/bz-pharma_2.jpg?width=1200&height=800&fit=crop)
Important Biotech Catalysts For September 8, 2022 - End Of The Day Summary
September 08, 2022
Via Benzinga
![](https://cdn.benzinga.com/files/images/story/2022/09/01/bz-pharma_4.jpg?width=1200&height=800&fit=crop)
Recap Of Thursday's Biotech Catalysts - End Of the Day Summary
September 01, 2022
Via Benzinga
![](https://cdn.benzinga.com/files/images/story/2022/09/01/bz-pharma.jpg?width=1200&height=800&fit=crop)
![](https://cdn.benzinga.com/files/images/story/2022/08/31/biotech6.jpg?width=1200&height=800&fit=crop)
Via Benzinga
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.